Scientists ID Genes Affecting MS Patient Response To Copaxone

A group of Israeli scientists from the Technion Israel Institute of Technology, the Weizmann Institute of Science, and Teva Pharmaceutical Industries have recently identified genes responsible for the positive response of many multiple sclerosis (MS) patients to the drug Copaxone®. These findings may contribute to the development of personalized medicine for MS sufferers.Copaxone® was the first original Israeli drug to be approved by the U.S. [click link for full article]

More: continued here

Filed under: Genetics on October 11th, 2007